The present invention provides a device for rejuvenating a region of skin or mucosal tissue, comprising: a pulsed electromagnetic frequency generator; a plurality of electrodes in communication with the pulsed electromagnetic frequency generator and an RF tissue diathermy device. The electrodes apply the pulsed electromagnetic power and the RF tissue diathermy to the tissue, heating it such that one portion of the region of mucosal tissue is maintained at a predetermined temperature range T.sub.1 while another portion of the region of mucosal tissue is at least temporarily maintained at predetermined temperature range T.sub.2.

The present disclosure provides, in part, methods of treatment for Alzheimer’s disease comprising applying repetitive transcranial magnetic stimulation (rTMS) therapy to a patient in need thereof. The present disclosure also provides devices that generate a low intensity pulsed magnetic field and variable frequencies.

The present invention relates to a nanosatellite-substrate complex capable of regulating stem cell adhesion and differentiation, and a method for preparing the same. Moreover, the present invention relates to a method of regulating stem cell adhesion and differentiation by applying a magnetic field to the nanosatellite-substrate complex.

The present invention concerns a system for treating cancer or tumors by thermotherapy, comprising an expandable implant device, an excitation catheter and an electric power source, wherein the implant device configured for circumferentially subtending a vessel upon expansion of the implant device in said vessel, the implant device comprising a set of cross-connected conductors forming a circumferential structure with openings in between the conductors, said openings having a minimal opening distance when the implant device is expanded of at least 2 mm, wherein the excitation catheter comprises a longitudinal shaft with a distal end, a proximal end, and a longitudinal body in between, whereby the catheter comprises a longitudinal axis along the longitudinal shaft, and whereby the catheter further comprises an emitter coil at or near the distal end, and whereby the longitudinal body of the catheter further comprises a wiring lumen comprising electrical wiring extending from the distal end to the proximal end, and whereby the electrical wiring is connected at or near the distal end with the emitter coil, and wherein the electric power source is connectable, and preferably connected, to the wiring via the proximal end of the catheter shaft for the generation of a time-varying magnetic field with the emitter coil.

The present disclosure provides a combined Pulsed Electromagnetic Field (PEMF) therapy and Photobiomodulation (PBM) therapeutic device in the form of a flexible wearable that can be secured to a user's body part to apply targeted radiation to a desired area. The frequencies and pulse patterns of both types of radiation are controlled by a single controller of the device which can switch between a number of pre-set sequences and patterns. The device is wirelessly enabled to allow control via an external user device.

Cancer treatment methods using thermotherapy and/or enhanced immunotherapy are disclosed herein. In one embodiment, the method comprising the steps of: (i) applying controlled thermal energy at 40-43° C. for a first predetermined time period to damage and weaken tumor cells of a tumor in a patient; (ii) administering pulsed high intensity focused ultrasound (pHIFU) in a first ultrasound mode to the tumor cells in the patient so as to damage the tumor cells without increasing the thermal energy; and (iii) administering low intensity focused ultrasound (LIFU) in a second ultrasound mode to further damage the tumor cells at a temperature of 39-43° C. for a second predetermined time period while performing observation of the tumor cells by ultrasonic thermometry.

Proposed are a device for supporting height growth by using a pulsed micro-electromagnetic field, and a method for driving the device. According to an embodiment, the device may include an antenna band part including a first antenna and a second antenna which are provided inside a covering part that is configured to surround a joint and which are configured to generate a micro-magnetic field at the joint in a contactless manner, and may include a control unit configured to generate the micro-magnetic field by forming a high frequency voltage and providing the high frequency voltage to the antenna band part, the control unit being configured to adjust the formed high frequency voltage, on the basis of a sensing value of a micro-electromagnetic field sensed at the second antenna, such that a micro-magnetic field corresponding to a diameter of the joint is provided.

A cell destruction method includes providing an anionic biomarker that comprises a magnetic material such as an iron or an iron compound. The anionic biomarker is introduced into an organism having pathogen cells with a negative charge. The anionic biomarkers are attracted to the negative charges of the pathogen and couple thereto. The anionic biomarker may also have a coupler portion that further aids in the anionic biomarker coupling to and being bound to the pathogen cell and/or cell wall. An electric field may be produced to cause the anionic biomarkers and/or the negative charges of the pathogen cell to polarize on or along the pathogen cell. A magnetic field is directed to cause the anionic biomarker, or magnetic material thereof to move and damage the cell. The magnetic field may be an alternating magnetic field that causes the magnetic material to oscillate and damage the cell wall.

An apparatus and method collect and deactivate pathogens (for example, coronaviruses) within a magnetic particle in order to reduce the number of active pathogens in a body.

A method and apparatus for pulsed electromagnetic field therapy to one or more patients is disclosed. In some embodiments, a pulsed electromagnetic field (PEMF) therapy device may include a biometric authentication device to verify the identity of the patient. Prior to receiving treatment, the identity of the patient may be verified though the biometric authentication device. After the patient's identity is verified, the PEMF therapy device may receive a PEMF treatment plan for the patient that includes a PEMF applicator type, a treatment duration, and an energy level associated with the PEMF treatment.